Economic impact of treatment of subclinical mastitis in early lactation using intramammary nisin.

Treatment of subclinical mastitis (SCM) during lactation is rarely recommended due to concerns related to both antimicrobial usage and costs associated with milk discard. Nisin is a naturally produced antimicrobial peptide with a Gram-positive spectrum that, when given to dairy cows, does not require milk discard. We evaluated the economic impact of treatment of SCM during early lactation using a nisin-based intramammary treatment under different scenarios which included various treatment costs, milk prices, and cure rates. We stochastically simulated the dynamics of SCM detected during the first week of lactation. The net economic impact was expressed in US dollars per case. The probabilities of an event and their related costs were estimated using a model that was based on pathogen-specific assumptions selected from peer-reviewed articles. Nisin cure rates were based on results of pivotal studies included in the FDA approval submission. Based on our model, the average cost of a case of intramammary infection (i.e., only true positive cases) in early lactation was $170 (90th percentage range = $148 to $187), while the cost of a clinical mastitis case was $521 (90th percentage range = $435 to $581). Both estimates varied with etiology, parity, and stage of lactation. When comparing the net cost of SCM cases (i.e., CMT-positive tests) detected during the first week of lactation, nisin treatment generated an average positive economic impact of $19 per CMT-positive case. Use of nisin to treat SCM was beneficial 93% of the time. Based on the sensitivity analysis, treatment would result in an economically beneficial outcome for 95% and 73% of multiparous and primiparous cows, respectively. At the herd level, use of intramammary nisin to treat SCM in cows in early lactation was economically beneficial in most tested scenarios. However, economic impact was highly influenced by factors such as rate of bacteriological cure, cost of treatment, and parity of affected animal. These factors should be considered when deciding to use nisin as a treatment for SCM.

The costs of chronic mastitis: A simulation study of an automatic milking system farm.

Mastitis is a production disease in dairy farming that causes economic losses. Especially chronic mastitis (i.e., mastitis cases continuing longer than 28 days) can substantially affect the risk of transmission of intramammary infections (IMI) and total milk production losses. Insights into the impact of chronic mastitis on production and farm economics are needed to guide chronic mastitis decision-making. We aimed to estimate the costs of chronic mastitis with a Monte Carlo simulation model in which the costs of chronic mastitis were estimated as part of the total mastitis costs. The model simulated milk yields, IMI dynamics, somatic cell count (SCC), and pregnancy status on an average Dutch dairy farm with 100 cow places over 9 years. The model was parameterized using information from the literature and actual sensor data from automatic milking system (AMS) farms. The daily subclinical milk production losses were modeled using a generalized additive model and sensor data. Transmission of IMI was modeled as well. The model results indicated median total costs of mastitis of € 230 per generic IMI case (i.e., a weighted average of all pathogens). The most substantial cost factors were the extra mastitis cases due to transmission, culling, and milk production losses. Other significant costs originated from dry cow treatments and diverted milk. The model also indicated median total costs due to chronic mastitis of € 118 (51 % of the total mastitis costs). The share of chronic mastitis relative to the total mastitis costs was substantial. Transmission of contagious bacteria had the largest share among the chronic mastitis costs (51 % of the costs of chronic cases). The large share of chronic mastitis costs in the total mastitis costs indicates the economic importance of these mastitis cases. The results of the study point to the need for future research to focus on chronic mastitis and reducing its presence on the AMS dairy farm.

The economics of sensor-based management of dairy cow suboptimal mobility.

Suboptimal mobility (SOM) is a costly health condition in dairy production. Current SOM management is based on visual SOM detection by farm staff. This often leads to cows with severe SOM being detected and promptly treated, whereas the detection and subsequent treatment of cows with mild SOM is delayed or nonexistent resulting in prolonged cases of mild SOM being treated only at half-year routine hoof trimming. Using automatic SOM detection sensors may improve early detection of mild SOM allowing for improved SOM management. However, the economic value of these sensors used for sensor-based SOM management are not well known. The objective of this study was to evaluate the added economic value of automatic SOM detection sensors. A recently developed bioeconomic simulation model was extended to simulate a farm without and with automatic SOM detection sensors and farm economic performance comparisons were drawn. Moreover, for the farm with sensors, novel sensor-based SOM management strategies were designed. Within these sensor based-management strategies multiple scenarios with different sensor performance in terms of sensitivity, specificity, and mobility score detection were simulated. A new alert prioritization method was also introduced. Results from this study provide insights on the economic tradeoffs in production losses and additional labor costs for the different sensor-based management strategies, sensor performances, and alert prioritization. Simulations show that the added economic value of automatic SOM detection sensors are sensitive to the sensor-based management strategies, sensor performance, and the introduced alert prioritization method. Thirty-nine of the 80 simulated scenarios obtained a positive mean net economic sensor effect: the highest was €6,360 per year (€51/cow per yr). Based on evidence from our scenarios we suggest that twice-yearly routine hoof trimming with the addition of automatic SOM detection sensors should be replaced with cow specific hoof trimmer treatments following SOM detection by the sensor. Earlier detection and subsequent treatment of mild SOM resulted in economic gains when the alert prioritization method was introduced. Implementing automatic SOM detection sensor systems allows for many options to alter SOM management where improvements in farm economic performance can be achieved in combination with improved cow mobility. The implications for future research are discussed.

Analysis of Epidemiological and Economic Impact of Foot-and-Mouth Disease Outbreaks in Four District Areas in Thailand.

Foot and mouth disease (FMD) is one of the most important infectious animal diseases impacting livestock production in Thailand. Despite a national vaccination program, FMD outbreaks are reported every year. We studied the epidemiological impacts of FMD outbreaks in four districts of Thailand between 2015 and 2016. Epidemiological data were collected from 193 FMD-affected dairy farms, 55 FMD-affected beef farms, and 25 FMD-affected pig farms. A significant difference in morbidity rates were observed between the dairy farms in the different areas, which could be explained by the differences in FMD outbreak management in each area. The morbidity rates in dairy and beef cattle also significantly differed between each animal age category, with the lowest morbidity rate observed in calves. Remarkably, vaccination was not significantly associated with the morbidity rate. In addition, the economic impact of FMD was calculated for 60 dairy farms in Muak Lek district. The economic losses were determined as the sum of milk production loss, mortality loss, additional labor costs, and veterinary service and medical costs, which averaged 56 USD per animal on the farm (ranging from 2 to 377 USD). Milk loss had the largest economic impact, although it varied substantially between farms. The farm size and outbreak duration were significantly associated with the total economic losses per farm. These results affirm the substantial epidemiological and economic impact of FMD on farms in Thailand, emphasizing the importance of FMD control.

Simulating the mechanics behind sub-optimal mobility and the associated economic losses in dairy production.

Hoof disorders and sub-optimal mobility (SOM) are economically important health issues in dairy farming. Although the dynamics of hoof disorders have an important effect on cow mobility, they have not been considered in previous simulation models that estimate the economic loss of SOM. Furthermore, these models do not consider the varying severities of SOM. The objective of this study was to develop a novel bio-economic simulation model to simulate the dynamics of 8 hoof disorders: digital dermatitis (DD), interdigital hyperplasia (HYP), interdigital dermatitis/heel-horn erosion (IDHE), interdigital phlegmon (IP), overgrown hoof (OH), sole haemorrhage (SH), sole ulcer (SU) and white-line disease (WLD), their role in SOM, and estimate the economic loss of SOM in a herd of 125 dairy cows. A Reed-Frost model was used for DD and a Greenwood model for the other 7 hoof disorders. Economic analysis was conducted per mobility score according to a 5-point mobility scoring method (1 = perfect mobility; 5 = severely impaired mobility) by comparing a scenario with SOM and one without SOM. Parameters used in the model were based on literature and expert opinion and deemed credible during model validation rounds. Results showed that the mean cumulative incidence for maximum mobility scores 2-5 SOM episodes were respectively 34, 16, 7 and <1 episodes per 100 cows per pasture period and 39, 19, 8, <1 episodes per 100 cows per housing period. The mean total annual economic loss due to SOM resulting from the hoof disorders under study was €15,342: €122 per cow per year. The economic analysis uncovered direct economic losses that could be directly linked to SOM episodes and indirect economic losses that could not be directly linked to SOM episodes but arose due to the presence of SOM. The mean total annual direct economic loss for maximum mobility score 2-5 SOM episodes was €1129, €3098, €4354 and €480, respectively. The mean total annual indirect economic loss varied considerably between the 5th and 95th percentiles: €-6174 and €19,499, and had a mean of €6281. This loss was composed of additional indirect culling due to SOM (∼65%) and changes in the overall herd milk production (∼35%) because of additional younger replacement heifers entering the herd due to increased culling rates. The bio-economic model presented novel results with respect to indirect economic losses arising due to SOM. The results can be used to stimulate farmer awareness and promote better SOM management.

Antibiotic use and potential economic impact of implementing selective dry cow therapy in large US dairies.

In this study, our objectives were to evaluate the economic feasibility of implementing selective dry cow therapy (SDCT) in large US herds and to estimate the potential reduction in antibiotic use around the dry period if SDCT management is adopted. Cow-level data were obtained from the Dairy Herd Improvement Association (AgriTech, Visalia, CA) and individual dairy herds in California. Logistic regression models were used to predict the incidence risk of subclinical and clinical mastitis in the subsequent lactation for 96 last test-day somatic cell score categories. Linear programming was used to optimize the costs of dry cow therapy in 3 simulated large US dairy herds with different bulk tank somatic cell counts (BTSCC). The objective function was aimed at minimization of the total cost of mastitis around the dry period (TCMD), under a varying constraint of the maximum percentage of cows dried off with antibiotics. A sensitivity analysis was performed on milk price, dry-off antibiotic price, and risk ratio of mastitis in the subsequent lactation when no antibiotics and only teat sealant was used at dry-off. For all situations, blanket dry cow therapy was more expensive than SDCT. In a herd with medium BTSCC, the TCMD was $54.7 per primiparous dry cow and $58.5 per multiparous dry cow annually. In the optimal economic situation where SDCT was used, only 30% of primiparous cows received antibiotics, leading to a TCMD of $52.4 per primiparous dry cow, whereas 88% of multiparous cows received antibiotics, at a cost of $58.2 per multiparous dry cow. This corresponded with an overall reduction of 29% in the use of antibiotics around the dry period in a conservative scenario. This study showed that it is economically feasible to reduce antibiotic use associated with dry cow therapy in large US dairy herds. This contributes to the efforts of reducing antibiotic use worldwide.

Reducing Antimicrobial Use and Dependence in Livestock Production Systems: A Social and Economic Sciences Perspective on an Interdisciplinary Approach.

Objective: In livestock production, antimicrobial resistance (AMR) is considered an externality as it is the undesired result of preventive and curative antimicrobial use. To address this biosocial issue, our objective is to present an approach based on interdisciplinary research to develop strategies and policies that aim to contain AMR. Method: To do so, we addressed three fundamental questions on which control policies and strategies for agricultural pollution problems are centered in the light of AMR. To ensure the technical, economic, behavioral and political feasibility of the developed measures, we demonstrated the usefulness of systemic approaches to define who, what and how to target by considering the complexity in which the ultimate decision-maker is embedded. We then define how voluntary or compulsory behavioral change can be achieved via five routes, introducing a clear taxonomy for AMR Interventions. Finally, we present three criteria for ex-ante analysis and ex-post evaluation of policies and strategies. Conclusion: Interdisciplinary systemic approaches enable the development of AMR policies and strategies that are technically, politically, economically and, last but not least, behaviorally feasible by allowing the identification of (a) all actors influencing AMU in livestock production, (b) power relations between these actors, (c) adequate regulatory and intervention bases, (d) what behavioral change strategy to use, (e) whom should implement this, as well as the cost-effective assessment of combinations of interventions. Unfortunately, AMR policies and strategies are often investigated within different disciplines and not in a holistic and systemic way, which is why we advocate for more interdisciplinary work and discuss opportunities for further research.

An Empirical Analysis on the Longevity of Dairy Cows in Relation to Economic Herd Performance.

Several studies have stated the various effects of an increased dairy cow longevity on economic herd performance, but empirical studies are lacking. This study aimed to investigate the association between longevity of dairy cows and the economic performance of dairy herds based on longitudinal Dutch accounting data. Herd and farm accounting data (n = 855 herds) over the years 2007-2016 were analyzed. Herd data contained yearly averages on longevity features, herd size and several production variables. Longevity was defined as the age of cows at culling and by lifetime milk production of culled cows. Farm accounting data contained yearly averages on revenues, fixed and variable costs of the herds, by which gross margins were defined. Data was analyzed using generalized linear mixed modeling, with gross margin as dependent variable. The independent variables consisted of average age of culled cows, average lifetime production of culled cows, year, herd size, herd intensity (milk production per ha), herd expansion rate, soil type, milking system, successor availability, total full-time equivalent, heifer ratio (% of heifers per cow) and use of outsourced heifer rearing. Herd was included as a random effect to account for the heterogeneity among herds. Descriptive statistics showed that the average age of culled cows was 5.87 (STD = 0.78) years and the average lifetime milk production of culled cows was 31.87 (STD = 7.56) tons per cow with an average herd size of 89 cows (STD = 38.85). The average age of culled cows was stable over the 10 years (variation between 5.79 AND 5.90 years). The gross margin was on average €24.80/100 kg milk (STD = 4.67), with the lowest value in year 2009 and the highest value in year 2013. Gross margin was not significantly associated with age of culled cows and lifetime milk production of culled cows. Variance in longevity between herds was large (STD = 0.78 years) but herds with a higher longevity did not perform economically better nor worse than herds resulting in lower longevity. This indicates that, within current practice, there is potential for improving longevity in order to meet society's concerns on animal welfare and environmental pollution, without affecting the economic performance of the herd.

Farmers' willingness to pay for foot and mouth disease vaccine in different cattle production systems in Amhara region of Ethiopia.

Although foot and mouth disease (FMD) is endemic in Ethiopia, use of vaccines to control the disease has been practiced sparingly. This is due to perceived high cost of good quality FMD vaccine, and consequently limited availability of the vaccine in the market. This study was conducted to assess farmers' willingness to pay (WTP) for a quality FMD vaccine and identify factors that could potentially influence their WTP in Amhara region of Ethiopia. A total of 398 farmers from four districts that represent the mixed crop-livestock and market oriented production systems were enrolled for the study. The WTP was estimated using contingent valuation method with a double-bound dichotomous choice bid design. Interval regression analysis was used to estimate mean WTP and identify factors that influence it. The results showed that the mean WTP of all farmers was Ethiopian Birr (ETB) 58.23 (95% CI: 56.20-60.26)/annual dose. It was ETB 75.23 (95% CI: 72. 97-74.49) for market oriented farmers and ETB 42.6 (95%CI: 41.24-43.96) for mixed crop livestock farmers. Willingness to pay for the vaccine was significantly higher for farmers in market oriented system than in mixed crop livestock system. It was also significantly higher for farmers whose main livelihood is livestock than those whose main livelihood is other than livestock, and for farmers who keep exotic breed cattle and their crosses than those who keep only local cattle breeds. Willingness to pay significantly increased with increase in FMD impact perception and vaccine knowledge scores of farmers. The high mean WTP estimates showed that farmers are enthusiastic about using the FMD vaccine. Market-oriented farmers with higher willingness to pay may be more likely to pay full cost if official FMD vaccination is planned in the country than mixed crop livestock farmers. Animal health extension about livestock diseases impact and vaccines has a potential to increase farmers' uptake of vaccines for disease control.

Policy Perspectives of Dog-Mediated Rabies Control in Resource-Limited Countries: The Ethiopian Situation.

One Health disease-control programs are believed to be most effective when implemented within the population transmitting the disease. The World Health Organization (WHO) and partners have targeted the elimination of dog-mediated human rabies by 2030 primarily through mass dog vaccination. Mass vaccination, however, has been constrained by financial resource limitations. The current owner-charged dog vaccination strategy, used in most resource-limited countries like Ethiopia, has not reached the minimum coverage required to build population immunity. Dog vaccination is non-existing in most rural areas of Ethiopia, and coverage is <20% in urban areas. Although the health and economic benefits of rabies elimination outweigh the costs, the direct beneficiaries (public in general) and those who bear the costs (dog owners) are not necessarily the same. In this perspective paper, we aggregate evidence on the socioeconomic burden of rabies in Ethiopia as well as the implications for potential opportunities to control the disease and possibilities to obtain the required funding sources for evidence-based interventions in the control of rabies in Ethiopia.

Estimating the combined costs of clinical and subclinical ketosis in dairy cows.

Clinical ketosis (CK) and subclinical ketosis (SCK) are associated with lower milk production, lower reproductive performance, an increased culling of cows and an increased probability of other disorders. Quantifying the costs related to ketosis will enable veterinarians and farmers to make more informed decisions regarding the prevention and treatment of the disease. The overall aim of this study was to estimate the combined costs of CK and SCK using assumptions and input variables from a typical Dutch context. A herd level dynamic stochastic simulation model was developed, simulating 385 herds with 130 cows each. In the default scenario there was a CK probability of almost 1% and a SCK probability of 11%. The herds under the no risk scenario had no CK and SCK, while the herds under the high-risk scenario had a doubled probability of CK and SCK compared to the default scenario. The results from the simulation model were used to estimate the annual cash flows of the herds, including the costs related to milk production losses, treatment, displaced abomasum, mastitis, calf management, culling and feed, as well as the returns from sales of milk and calves. The difference between the annual net cash flows of farms in the no risk scenario and the default scenario provides the estimate of the herd level costs of ketosis. Average herd level costs of ketosis (CK and SCK combined) were €3,613 per year for a default farm and €7,371 per year for a high-risk farm. The costs for a single CK case were on average €709 (with 5 and 95 percentiles of €64 and €1,196, respectively), while the costs for a single SCK case were on average €150 (with 5 and 95 percentiles of €18 and €422, respectively) for the default farms. The differences in costs between cases occurred due to differences between cases (e.g., cow culled vs cow not culled, getting another disease vs not getting another disease).

Impact of One-Health framework on vaccination cost-effectiveness: A case study of rabies in Ethiopia.

Livestock losses due to rabies and health and the corresponding benefits of controlling the disease are not often considered when the cost-effectiveness of rabies control is evaluated. In this research, assessed the benefits of applying a One Health perspective that includes these losses to the case of canine rabies vaccination in Ethiopia. We constructed a dynamic epidemiological model of rabies transmission. The model was fit to district-specific data on human rabies exposures and canine demography for two districts with distinct agro-ecologies. The epidemiological model was coupled with human and livestock economic outcomes to predict the health and economic impacts under a range of vaccination scenarios. The model indicates that human exposures, human deaths, and rabies-related livestock losses would decrease monotonically with increasing vaccination coverage. In the rural district, all vaccination scenarios were found to be cost-saving compared to the status quo of no vaccination, as more money could be saved by preventing livestock losses than would be required to fund the vaccination campaigns. Vaccination coverages of 70% and 80% were identified as most likely to provide the greatest net health benefits at the WHO cost-effectiveness threshold over a period of 5 years, in urban and rural districts respectively. Shorter time frames led to recommendations for higher coverage in both districts, as did even a minor threat of rabies re-introduction. Exclusion of rabies-related livestock losses reduced the optimal vaccination coverage for the rural district to 50%. This study demonstrated the importance of including all economic consequences of zoonotic disease into control decisions. Analyses that include cattle and other rabies-susceptible livestock are likely better suited to many rural communities in Africa wishing to maximize the benefits of canine vaccination.

Economic and epidemiological impact of different intervention strategies for subclinical and clinical mastitis.

The objective of this study was to evaluate and compare different combinations of intervention strategies for contagious or opportunistic subclinical and clinical intramammary infections (IMI). We simulated two different Danish dairy cattle herds with ten different intervention strategies focusing on cow-specific treatment or culling, including three baseline strategies without subclinical interventions. In one herd, the main causative pathogen of IMI was Staphylococcus (S.) aureus. In the other herd, Streptococcus (St.) agalactiae was the main causative agent. For both herds, we investigated costs and effectiveness of all ten intervention strategies. Intervention strategies consisted of measures against clinical and subclinical IMI, with baselines given by purely clinical intervention strategies. Our results showed that strategies including subclinical interventions were more cost-effective than the respective baseline strategies. Increase in income and reduction of IMI cases came at the cost of increased antibiotic usage and an increased culling rate in relation to IMI. However, there were differences between the herds. In the St. agalactiae herd, the clinical intervention strategy did not seem to have a big impact on income and number of cases. However, intervention strategies which included cow-specific clinical interventions led to a higher income and lower number of cases in the S. aureus herd. The results show that intervention strategies including interventions against contagious or opportunistic clinical and subclinical IMI can be highly cost-effective, but should be herd-specific.

Economic evaluation of 4 bovine leukemia virus control strategies for Alberta dairy farms.

Bovine leukemia virus (BLV) is a production-limiting disease common in North American dairy herds. To make evidence-based recommendations to Canadian dairy producers and their consultants regarding cost and financial benefits of BLV on-farm control, an economic model that takes the supply-managed milk quota system into account is necessary. Alberta-specific input variables were used for the presented analysis. A decision tree model program was used to evaluate economic aspects of decreasing a 40% BLV within-herd prevalence on dairy farms by implementing various control strategies over 10 yr. Investigated strategies were (1) all management strategies, including 3 options for colostrum management; (2) some management strategies; (3) test and cull; and (4) test and segregate. Each of these strategies was compared with a no control on-farm approach. The prevalence for this no-control approach was assumed to stay constant over time. Each control strategy incurred specific yearly cost and yielded yearly decreases in prevalence, thereby affecting yearly partial net revenue. Infection with BLV was assumed to decrease milk production, decrease cow longevity, and increase condemnation of carcasses at slaughter from cattle with enzootic bovine leukosis, thereby decreasing net revenue. Cows infected with BLV generated a yearly mean partial net revenue of Can$7,641, whereas noninfected cows generated Can$8,276. Mean cost for the control strategies ranged from Can$193 to Can$847 per animal over 10 yr in a 146-animal herd. Net benefits of controlling BLV on farm, as compared with not controlling BLV, per cow in a 146-animal herd over a 10-yr period for each strategy was: Can$1,315 for all management strategies (freezer); Can$1,243 for all management strategies (pasteurizer); Can$785 for all management strategies (powdered colostrum); Can$1,028 for some management strategies; Can$1,592 for test and cull; and Can$1,594 for test and segregate. Consequently, on-farm BLV control was financially beneficial. Even though negative net benefits were possible and expected for some iterations, our sensitivity analysis highlighted the overall robustness of our model. In summary, this model provided evidence that Canadian dairy farmers should be encouraged to control BLV on their farm.

An economic assessment of pseudorabies (Aujeszky' disease) elimination on hog farms in China.

Hog pseudorabies (Aujeszky's disease) can incur serious losses for farm owners and even the entire hog industry by causing infertility, abortion, and stillbirth among sows, as well as diarrhoea, respiratory failure, and death among piglets. Pseudorabies virus could be prevented, controlled, and eliminated by clean-up at both farm and regional levels through a strict procedure of vaccination, quarantine, diagnosis, elimination of positive animals, and healthy animals nurturing. Using data from 63 large-scale hog farms from nine provinces (municipalities, autonomous regions) of China, we evaluated the economic consequences of hog pseudorabies clean-up in China's hog farms based on a partial budgeting method. By comparing large-scale hog farms that have performed pseudorabies clean-up with similar farms that have not, we analysed how clean-up affected farm profit and whether there existed sufficient economic incentives for farm owners to adopt pseudorabies control measures. Further, we examined how the economic consequences varied with factors such as clean-up history and farm size. The findings showed that, on average, clean-up adopters outperformed non-adopters by 8.02 million yuan per farm per year within the four years post clean-up adoption. Also, we found that the net profit changes attributable to pseudorabies clean-up increased over time and with farm size. Although we cannot extrapolate to all Chinese hog farms, these findings suggest that the earlier a hog farm adopted pseudorabies clean-up, the larger the economic benefits would be, especially for large-scale farms.

Economic and epidemiological impact of different intervention strategies for clinical contagious mastitis.

The overall aim of this study was to compare different intervention strategies for clinical intramammary infections (IMI). We conducted a simulation study to represent a Danish dairy cattle herd with IMI caused mostly by Staphylococcus aureus and 9 different intervention strategies for clinical IMI. A standard intervention of 3 d of treatment consisting of intramammary injections for all clinical cases was used. Two of the strategies reflected the use of more antibiotics and 6 strategies reflected cow-specific treatment or culling decisions. For these strategies, we assessed the cost and effectiveness of culling as an IMI intervention. Our results showed that nearly all strategies could reduce the number of IMI cases [e.g., a median of 37 clinical cases with the extended intramammary treatment over 5 d strategy (Basic5) and 30 clinical cases with the cow culled with recovery probability below 50% (Before50)] compared with the standard intervention (median of 42 clinical cases). This happened alongside either increased antibiotic usage (e.g., from a median of 123 treatment days up to 179 treatment days with strategy Basic5) or an increased number of cows culled in relation to IMI (e.g., from a median of 16 up to 24 cows with strategy Before50). Strategies with more antibiotics or reactive culling had a slightly higher net income (e.g., €190,014 median net income with strategy Basic5 or €196,995 with strategy Before50 compared with €187,666 with the standard strategy). This shows that a cow-specific clinical intervention approach can be cost-effective in reducing IMI incidence.

Herd-Level Mastitis-Associated Costs on Canadian Dairy Farms.

Mastitis imposes considerable and recurring economic losses on the dairy industry worldwide. The main objective of this study was to estimate herd-level costs incurred by expenditures and production losses associated with mastitis on Canadian dairy farms in 2015, based on producer reports. Previously, published mastitis economic frameworks were used to develop an economic model with the most important cost components. Components investigated were divided between clinical mastitis (CM), subclinical mastitis (SCM), and other costs components (i.e., preventive measures and product quality). A questionnaire was mailed to 374 dairy producers randomly selected from the (Canadian National Dairy Study 2015) to collect data on these costs components, and 145 dairy producers returned a completed questionnaire. For each herd, costs due to the different mastitis-related components were computed by applying the values reported by the dairy producer to the developed economic model. Then, for each herd, a proportion of the costs attributable to a specific component was computed by dividing absolute costs for this component by total herd mastitis-related costs. Median self-reported CM incidence was 19 cases/100 cow-year and mean self-reported bulk milk somatic cell count was 184,000 cells/mL. Most producers reported using post-milking teat disinfection (97%) and dry cow therapy (93%), and a substantial proportion of producers reported using pre-milking teat disinfection (79%) and wearing gloves during milking (77%). Mastitis costs were substantial (662 CAD per milking cow per year for a typical Canadian dairy farm), with a large portion of the costs (48%) being attributed to SCM, and 34 and 15% due to CM and implementation of preventive measures, respectively. For SCM, the two most important cost components were the subsequent milk yield reduction and culling (72 and 25% of SCM costs, respectively). For CM, first, second, and third most important cost components were culling (48% of CM costs), milk yield reduction following the CM events (34%), and discarded milk (11%), respectively. This study is the first since 1990 to investigate costs of mastitis in Canada. The model developed in the current study can be used to compute mastitis costs at the herd and national level in Canada.

Addition of meloxicam to the treatment of bovine clinical mastitis results in a net economic benefit to the dairy farmer.

Recently, it has been shown that the addition of meloxicam to standard antimicrobial therapy for clinical mastitis (CM) improves the conception rate of dairy cows contracting CM in the first 120 d in milk. The objective of our study was to assess whether this improved reproduction through additional treatment with meloxicam would result in a positive net economic benefit for the farmer. We developed a stochastic bio-economic simulation model, in which a dairy cow with CM in the first 120 d in milk was simulated. Two scenarios were simulated in which CM cases were treated with meloxicam in conjunction with antimicrobial therapy or with antimicrobial therapy alone. The scenarios differed for conception rates (31% with meloxicam or 21% without meloxicam) and for the cost of CM treatment. Sensitivity analyses were undertaken for the biological and economic components of the model to assess the effects of a wide range of inputs on inferences about the cost effectiveness of meloxicam treatment. Model results showed an average net economic benefit of €42 per CM case per year in favor of the meloxicam scenario. Cows in the no-meloxicam treatment scenario had higher returns on milk production, lower costs upon calving, and reduced costs of treatment. However, these did not outweigh the savings associated with lower feed intake, reduced number of inseminations, and the reduced culling rate. The net economic benefit favoring meloxicam therapy was a consequence of the better reproductive performance in the meloxicam scenario in which cows had a shorter calving to conception interval (132 vs. 143 d), a shorter intercalving interval (405 vs. 416 d), and fewer inseminations per conception (2.9 vs. 3.7) compared with cows in the no-meloxicam treatment scenario. This resulted in a shorter lactation, hence a lower lactational milk production (8,441 vs. 8,517 kg per lactation) with lower feeding costs in the meloxicam group. A lower culling rate (12 vs. 25%) resulted in lower replacement costs in the meloxicam treatment scenario. All of the scenarios evaluated in the sensitivity analyses favored meloxicam treatment over no meloxicam. This study demonstrated that improvements in conception rate achieved by the use of meloxicam, as additional therapy for mild to moderate CM in the first 120 d in milk, have positive economic benefits. This inference remained true over a wide range of technical and economic inputs, demonstrating that use of meloxicam is likely to be cost effective across many production systems.

Cost-effectiveness of mass dog rabies vaccination strategies to reduce human health burden in Flores Island, Indonesia.

The cost-effectiveness of different mass dog rabies vaccination strategies, defined as the costs per year of life lost (YLL) averted was evaluated for a period of 10 years by means of a dynamic simulation study for a typical village on Flores Island. In the base strategy (no dog vaccination and no post-exposure treatment (PET) of human bite cases), the model showed that the introduction of the virus by one infectious dog into an isolated village with 1500 inhabitants and 400 dogs resulted in 881 YLLs during a 10-year simulation period, which is equivalent to 30 human rabies cases. An annual dog vaccination campaign with a coverage of 70% using a short-acting vaccine saved 832 YLLs, while the cumulative costs for the public sector were US$3646 or US$4.38 per YLL averted. Switching to a long-acting vaccine, the annual vaccination strategies with a coverage of 50% (AV_156_50) or 70% (AV_156_70) reduced the baseline YLLs from 881 to respectively 78 and 26 YLLs with cumulative costs of US$3716 and US$2264 or US$4.63 and US$2.65 per YLL averted, respectively. In general, dog vaccination was more cost-effective than PET alone (US$2.65-4.63 per YLL averted versus US$23.29 per YLL averted). Although a combination of PET with AV_156_70 was less cost-effective compared to AV_156_70 alone, this strategy was able to prevent all human deaths due to rabies. A combination of PET with annual vaccination using a short-acting vaccine at a coverage of 50% was far from being cost-effective, suggesting that the currently applied rabies control in Flores Island is not an efficient investment in reducing human rabies burden. An increased investment in either an increase in the current coverage or in a switch from the short-acting vaccine to the long-acting vaccine type would certainly pay off.